June 5 (Reuters) - Noxopharm NOX.AX
* NOX66 confirmed non-toxic. Trial cleared for full enrolment
* Review has shown that 14 continuous days of NOX66 therapy was not associated with any adverse events, clearing way for resumption Source text for Eikon: Further company coverage: NOX.AX